SciSparc (SPRC) SEC Filings: History & Chart

SciSparc Ltd.(SPRC)

Biotechnology · Tel Aviv, TA

$4.33-0.03 (-0.69%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About SciSparc Ltd.

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.

Tel Aviv, TA

3 employees

scisparc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Oz Adler

View full financials

Form	Filing Date	Accepted	Document
6-K	Sep 30, 2026	Sep 30, 2026	View filing
6-K	Sep 24, 2026	Sep 24, 2026	View filing
6-K	Sep 2, 2026	Sep 2, 2026	View filing
EFFECT	Aug 31, 2026	Sep 1, 2026	View filing
6-K	Aug 26, 2026	Aug 26, 2026	View filing
6-K	Aug 24, 2026	Aug 24, 2026	View filing
F-3/A	Aug 19, 2026	Aug 19, 2026	View filing
20-F/A	Aug 19, 2026	Aug 19, 2026	View filing
6-K	Aug 18, 2026	Aug 18, 2026	View filing
6-K	Aug 12, 2026	Aug 12, 2026	View filing
6-K	Aug 5, 2026	Aug 5, 2026	View filing
6-K	Jul 31, 2026	Jul 31, 2026	View filing
6-K	Jul 29, 2026	Jul 29, 2026	View filing
6-K	Jul 15, 2026	Jul 15, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
3/A	Jul 13, 2026	Jul 13, 2026	View filing
6-K	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 3, 2026	Jun 3, 2026	View filing
6-K	May 29, 2026	May 29, 2026	View filing
SC 13G/A	May 15, 2026	May 15, 2026	View filing
6-K	May 11, 2026	May 11, 2026	View filing
20-F	Apr 29, 2026	Apr 29, 2026	View filing
3	Mar 23, 2026	Mar 23, 2026	View filing

SEC Filings

Recent Filings